Cantargia AB | Ownership

Companies that own Cantargia AB

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Första AP-fonden
4,550,000
6.88%
4,550,000
0.07%
01/19/2018
Fjärde AP-fonden
2,750,000
4.16%
2,750,000
0.03%
01/19/2018
Andra AP-fonden
2,200,000
3.32%
2,200,000
0.03%
01/19/2018
SEB Investment Management AB
1,998,350
3.02%
1,998,350
0.01%
01/19/2018
Handelsbanken Fonder AB
1,000,000
1.51%
1,000,000
0.02%
01/19/2018

About Cantargia AB

View Profile
Address
Medicon Village
Lund SN 223 81
Sweden
Employees -
Website http://www.cantargia.com
Updated 09/14/2018
Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. It focuses on the development of CAN04 for the treatment of non-small cell lung cancer and pancreatic cancer. The company was founded by Thoas Michael Fioretos, Kjell Torsten Sjostrom, and Marcus Jaras on October 26, 2009 and is headquartered in Lund, Sweden.